Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited Metastatic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03030131
What this trial is testing

Immune Neoadjuvant Therapy Study of Durvalumab in Early Stage Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Intergroupe Francophone de Cancerologie Thoracique 50
Testing effectiveness (Phase 2)Looking for participantsNCT07796880
What this trial is testing

Neoadjuvant Culmerciclib Combined With Endocrine Therapy for Hormone Receptor-Positive， Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

Who this might be right for
Hormone Receptor-Positive Breast CancerHER2 Low Breast CarcinomaEarly-Stage Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 80
Not applicableLooking for participantsNCT03706027
What this trial is testing

Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer

Who this might be right for
Lung Cancer
University of Rochester 100
Not applicableUnknownNCT02987127
What this trial is testing

Prospective Study of Frontline H Pylori Eradication in the Treatment of Early-stage Extragastric MALT Lymphoma

Who this might be right for
Mucosa-Associated Lymphoid Tissue Lymphoma
National Taiwan University Hospital 21
Large-scale testing (Phase 3)Not Yet RecruitingNCT06789796
What this trial is testing

QL1706 or QL1604 in Patients With Limited-stage Small Cell Lung Cancer After Chemoradiotherapy.

Who this might be right for
Small-cell Lung Cancer
Qilu Pharmaceutical Co., Ltd. 636
Not applicableStudy completedNCT04095169
What this trial is testing

Biomarkers in Early-stage Spondyloarthritis

Who this might be right for
Ankylosing SpondylitisSpondyloarthritis
Spine Centre of Southern Denmark 216
Testing effectiveness (Phase 2)Study completedNCT00004762
What this trial is testing

Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosing Cholangitis

Who this might be right for
Cholangitis, Sclerosing
National Center for Research Resources (NCRR) 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07305246
What this trial is testing

Clinical Study of SHR-A1811 With or Without Letrozole in Neoadjuvant Therapy for Early-Stage HR-Positive, HER2-Low Breast Cancer

Who this might be right for
Breast Cancer
First Hospital of China Medical University 120
Large-scale testing (Phase 3)Not Yet RecruitingNCT05699746
What this trial is testing

CAPEOX vs Observation in Colorectal Cancer Patients With Positive MRD

Who this might be right for
Colorectal Cancer
Zhejiang University 38
Not applicableEnrolling By InvitationNCT07372261
What this trial is testing

Validation of a Prognostic Method for Assessing the Risk of Distant Metastasis in Early-stage Breast Cancer

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Casa Sollievo della Sofferenza IRCCS 1,000
Large-scale testing (Phase 3)Ended earlyNCT00687986
What this trial is testing

Trial of Either Surgery or Stereotactic Radiotherapy for Early Stage (IA) Lung Cancer

Who this might be right for
Lung Cancer
Amsterdam UMC, location VUmc 22
Not applicableStudy completedNCT00827307
What this trial is testing

Zoladex Plus Tamoxifen in Breast Cancer

Who this might be right for
MammographyEstrogenLipemia+2 more
Zhejiang Cancer Hospital 100
Not applicableStudy completedNCT01448447
What this trial is testing

Phase IV Trial to Evaluate Breast Brachytherapy Using the Mammosite-Ml®

Who this might be right for
Breast CancerDuctal Carcinoma in Situ
Mercy Research 20
Testing effectiveness (Phase 2)Ended earlyNCT04862455
What this trial is testing

NBTXR3, Radiation Therapy, and Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Cancer

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
M.D. Anderson Cancer Center 14
Not applicableNot Yet RecruitingNCT07339384
What this trial is testing

Signatera Assessment in Early-Stage Endometrial Cancer

Who this might be right for
Endometrial Cancer
Natera, Inc. 1,010
Testing effectiveness (Phase 2)Study completedNCT03936452
What this trial is testing

Combined Treatment of Sintilimab, Peg-aspargase Plus Anlotinib in NK/T Cell Lymphoma

Who this might be right for
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeEarly StageAnlotinib+5 more
Sun Yat-sen University 55
Not applicableLooking for participantsNCT05509998
What this trial is testing

Reducing the Duration of Untreated Psychosis in the United States: The Impact of Screening and Systematic Communication

Who this might be right for
First Episode Psychosis (FEP)Clinical High Risk for Psychosis (CHR)
Icahn School of Medicine at Mount Sinai 912
Not applicableStudy completedNCT07405047
What this trial is testing

Fractionated Stereotactic Radiotherapy for Limited Small Volume Brain Metastases

Who this might be right for
Brain Metastases, Adult
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 33
Large-scale testing (Phase 3)Study completedNCT02635009
What this trial is testing

Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CarcinomaLimited Stage Small Cell Lung Carcinoma
NRG Oncology 418
Not applicableStudy completedNCT01017549
What this trial is testing

Post Market Study Using the Xoft Axxent System

Who this might be right for
Breast Cancer
Xoft, Inc. 44
Next Page